BioInsights - De-risking late-stage activities by retaining your early-stage expertise

CELL AND GENE THERAPY MANUFACTURING SCALE-UP/ SCALE-OUT

De-risking late-stage activities by retaining your early-stage expertise

Cell & Gene Therapy Insights 2022; 8(8), 921–923

10.18609/cgti.2022.137

Published: 27 August
Editorial
Nolan Sutherland

“...as innovators in science and technology we should apply the same ‘thinking outside the box’ strategy to managing our expertise”